The buzzy A24 documentary "You Can See Everything," which chronicles Elizabeth Holmes in the weeks before her prison sentence, drives trader sentiment ahead of its October 16 limited release. Universal critical acclaim, including a 98 Metascore from early festival screenings at Telluride and New York, combined with Nathan Fielder’s involvement and a viral teaser, has fueled anticipation for a solid debut. Yet the market’s fragmented odds—led by 7m+ at 26%—reflect uncertainty over a three-hour R-rated documentary’s theatrical ceiling in limited play, where A24 expansions and word-of-mouth will determine whether it exceeds or falls short of mid-six-figure tracking. Key swing factors include opening-weekend screen counts and any late October competition.